Ventripoint Diagnostics Ltd. is delighted to welcome Bart Hendriks as the company's new Strategic Partnerships Executive, to accelerate adoption of Ventripoint’s AI powered, heart-scanning technology by hospitals and clinics in Europe and around the world.
A seasoned professional in the MedTech artificial intelligence field, Bart brings a wealth of experience from his tenure in various leadership capacities, including CEO and Founder of innovative ventures in medical technology, diagnostics, and AI-driven clinical applications.
Based in The Netherlands, Bart will focus on expanding European and global sales of Ventripoint’s technology, which analyses ultrasound scans and provides MRI-quality measurements of the heart, at the fraction of the cost and time and trauma of MRIs.
“Bart has excelled in global sales and marketing management, strategic partner development, change management, and has shown adeptness in mergers and acquisitions, deal structuring, negotiations and team leadership,” said Ventripoint’s Interim CEO Hugh MacNaught. “Our focus is now commercialization of Ventripoint’s technology. Bart’s track record includes successfully closing multiple funding rounds, securing strategic contracts, and driving substantial revenue growth across different organizations.“
Added Hendriks: “Ventripoint's technology is unique, offering a revolutionary mix of precision, efficiency, and user-friendliness in cardiac diagnostics using artificial intelligence. This cuttingedge tool is set to alter the paradigm of heart health management, making cardiac scans more accessible and effective for patients across the globe, and offers a portable, inexpensive alternative to MRIs that takes only minutes.”
Source: Ventripoint Diagnostics Ltd.
Image Source: LinkedIn
